Owner/approver: COO Farming
Valid from: 2022-03-29
Lerøy Seafood Group (Lerøy) emphasises the importance of preventive operating practice, aiming to reduce the number of incidences involving disease in fish. In certain situations, however, the disease and needs may require use of antimicrobial agents to treat disease in fish.
The purpose of this policy is to provide a principal description of how the Group approaches use of antimicrobial agents.
This policy applies to all the Group's farming operations.
Antimicrobial agents: Active substances used to treat bacterial infections and classified as medicines by Norwegian medicines legislation. Antimicrobial agents are only used when medical indications imply that they are needed.
Antibiotic resistance: The ability of bacteria to resist the effect of antibiotics. Antibiotic resistance is caused by use of antibiotics, and the most important measure in preventing the development of antibiotic resistance is to reduce the use of antibiotics.
Use of antimicrobial agents:
Lerøy aims to avoid unnecessary use of antimicrobial agents. To achieve this, a number of different preventive measures are implemented and are part of a preventive operating practice including vaccination, risk management, disease control, structural measures, early diagnoses etc.
The use of antimicrobial agents is seen as a last line of defence and only applied in situations where deemed necessary to protect fish welfare, and when factors relating to food safety, the environment, resistance and effect have been clarified.
Moreover, antimicrobial agents are only used when prescribed by authorised fish health personnel, and the only agents used are those approved by Norwegian medicines authorities.
Prevention of antibiotic resistance:
In situations that require the use of antibiotics, the risk of resistance development is managed by means of the following principles:
Roles and responsibilities
Policy ownership and implementation